InsiderTrades

Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001870913-23-000020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2023-12-19 2023-12-15+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $52.55 -50.0K 957.6K -5% -$2.63M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-19 S D 25,000 $52.65 932,620 I Held by Esjay LLC — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.45 to $53.19, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2023-12-15 S D 11,974 $52.44 970,646 I Held by Esjay LLC — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.97 to $52.97, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2023-12-18 S D 13,026 $52.44 957,620 I Held by Esjay LLC — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.02 to $52.97, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.